speb/financial-data huggingface dataset:
ONMD income_statement (quarterly, 2025-03-31) — Other Income Expense: 353000.00
ONMD cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 524000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 128000.00
ONMD income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 163000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Other Payable: 3262000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 793000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Payables: 10132000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 10132000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
ONMD income_statement (quarterly, 2025-03-31) — Pretax Income: -1902000.00
ONMD cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -5000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Receivables: 247000.00
ONMD income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 361000.00
ONMD income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 12000.00
ONMD cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -94000.00
ONMD income_statement (quarterly, 2025-03-31) — Research And Development: 348000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -103471000.00
ONMD income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 290000.00
ONMD income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1652000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Share Issued: 30760576.00
ONMD cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 0.00
ONMD cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 208000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -16550000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -16550000.00
ONMD income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ONMD income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
ONMD balance_sheet (quarterly, 2025-03-31) — Total Assets: 1732000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -16550000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Total Debt: 7519000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -16550000.00
ONMD income_statement (quarterly, 2025-03-31) — Total Expenses: 2361000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 18282000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 101000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 128000.00
ONMD income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -2224000.00
ONMD income_statement (quarterly, 2025-03-31) — Total Unusual Items: 190000.00
ONMD income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 190000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 187745.00
ONMD balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 529000.00
ONMD cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -30000.00
ONMD balance_sheet (quarterly, 2025-03-31) — Working Capital: -16523000.00
ONMD income_statement (quarterly, 2025-06-30) — +Operating Expense: 1822000.00
ONMD income_statement (quarterly, 2025-06-30) — +Total Revenue: 155000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 254000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 97176000.00
ONMD income_statement (quarterly, 2025-06-30) — Basic Average Shares: 36835945.00
ONMD income_statement (quarterly, 2025-06-30) — Basic EPS: 0.07
ONMD cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 144000.00
ONMD cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 122000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1720000.00
ONMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 3026000.00
ONMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -670000.00
ONMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2378000.00
ONMD cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 9000.00
ONMD cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -690000.00
ONMD cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 154000.00
ONMD cash_flow (quarterly, 2025-06-30) — Change In Receivables: -7000.00
ONMD cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -534000.00
ONMD cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -7000.00
ONMD cash_flow (quarterly, 2025-06-30) — Changes In Cash: -22000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -3840000.00
ONMD income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 396000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 4519000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Current Assets: 2267000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Current Debt: 400000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 400000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 512000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 512000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 6159000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Current Notes Payable: 0.00
ONMD cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 34000.00
ONMD cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 34000.00
ONMD income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 38405921.00
ONMD income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.07
ONMD income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2982000.00
ONMD income_statement (quarterly, 2025-06-30) — EBIT: 3004000.00
ONMD income_statement (quarterly, 2025-06-30) — EBITDA: 3038000.00
ONMD cash_flow (quarterly, 2025-06-30) — End Cash Position: 122000.00
ONMD cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 3026000.00
ONMD cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2381000.00
ONMD cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -423000.00
ONMD income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 250000.00
ONMD income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1183000.00
ONMD income_statement (quarterly, 2025-06-30) — Gross Profit: -241000.00
ONMD cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
ONMD income_statement (quarterly, 2025-06-30) — Interest Expense: 22000.00
ONMD income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 22000.00
ONMD cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 3000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Invested Capital: -3440000.00
ONMD cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -670000.00
ONMD cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
ONMD cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
ONMD cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 94000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Net Debt: 278000.00
ONMD income_statement (quarterly, 2025-06-30) — Net Income: 2982000.00
ONMD income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2982000.00
ONMD income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2982000.00
ONMD income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2982000.00
ONMD income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2982000.00
ONMD cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2982000.00
ONMD income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2982000.00
ONMD income_statement (quarterly, 2025-06-30) — Net Interest Income: -22000.00
ONMD cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -168000.00
ONMD cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 94000.00
ONMD income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -22000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Net PPE: 70000.00
ONMD cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3000.00
ONMD cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -262000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -3840000.00
ONMD income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -919000.00
ONMD income_statement (quarterly, 2025-06-30) — Normalized Income: -144030.00
ONMD cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2378000.00
ONMD cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -423000.00
ONMD income_statement (quarterly, 2025-06-30) — Operating Income: -2063000.00
ONMD income_statement (quarterly, 2025-06-30) — Operating Revenue: 155000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 46095647.00
ONMD balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 293000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 400000.00
ONMD income_statement (quarterly, 2025-06-30) — Other Gand A: 1183000.00
ONMD income_statement (quarterly, 2025-06-30) — Other Income Expense: 5067000.00
ONMD cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -5471000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 18000.00
ONMD income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1110000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Other Payable: 728000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 1598000.00
ONMD income_statement (quarterly, 2025-06-30) — Other Special Charges: -3707000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Payables: 728000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5247000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
ONMD income_statement (quarterly, 2025-06-30) — Pretax Income: 2982000.00
ONMD cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Receivables: 254000.00
ONMD income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 396000.00
ONMD income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 34000.00
ONMD cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -168000.00
ONMD income_statement (quarterly, 2025-06-30) — Research And Development: 382000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -100489000.00
ONMD income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 257000.00
ONMD income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1440000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Share Issued: 46283392.00
ONMD cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 0.00
ONMD income_statement (quarterly, 2025-06-30) — Special Income Charges: 3707000.00
ONMD cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 197000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -3840000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -3840000.00
ONMD income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 830970.00
ONMD income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
ONMD balance_sheet (quarterly, 2025-06-30) — Total Assets: 2337000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -3840000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Total Debt: 400000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -3840000.00
ONMD income_statement (quarterly, 2025-06-30) — Total Expenses: 2218000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 6177000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 70000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 18000.00
ONMD income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -2063000.00
ONMD income_statement (quarterly, 2025-06-30) — Total Unusual Items: 3957000.00
ONMD income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 3957000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 187745.00
ONMD balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 529000.00
ONMD cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 803000.00
ONMD balance_sheet (quarterly, 2025-06-30) — Working Capital: -3892000.00
ONMD income_statement (quarterly, 2025-09-30) — +Operating Expense: 2013000.00
ONMD income_statement (quarterly, 2025-09-30) — +Total Revenue: 177000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 582000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 97818000.00
ONMD income_statement (quarterly, 2025-09-30) — Basic Average Shares: 52618031.00
ONMD income_statement (quarterly, 2025-09-30) — Basic EPS: -0.01
ONMD cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 122000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 149000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 749000.00
ONMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 477000.00
ONMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 1108000.00
ONMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1558000.00
ONMD cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 226000.00
ONMD cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 432000.00
ONMD cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 178000.00
ONMD cash_flow (quarterly, 2025-09-30) — Change In Receivables: -328000.00
ONMD cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 508000.00
ONMD cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -328000.00
ONMD cash_flow (quarterly, 2025-09-30) — Changes In Cash: 27000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -3939000.00
ONMD cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
ONMD income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 399000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 3120000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Current Assets: 1446000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Current Debt: 388000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 388000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 770000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 770000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5005000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 0.00
ONMD cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 10000.00
ONMD cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 10000.00
ONMD income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 52618031.00
ONMD income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.01
ONMD income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -741000.00
ONMD income_statement (quarterly, 2025-09-30) — EBIT: -735000.00
ONMD income_statement (quarterly, 2025-09-30) — EBITDA: -725000.00
ONMD cash_flow (quarterly, 2025-09-30) — End Cash Position: 149000.00
ONMD cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 477000.00
ONMD cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1558000.00
ONMD cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 399000.00
ONMD income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -313000.00
ONMD income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1386000.00
ONMD income_statement (quarterly, 2025-09-30) — Gross Profit: -222000.00
ONMD cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
ONMD income_statement (quarterly, 2025-09-30) — Interest Expense: 6000.00
ONMD income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 6000.00
ONMD cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 25000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Invested Capital: -3551000.00
ONMD cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 1108000.00
ONMD cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
ONMD cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
ONMD cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
ONMD cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -11000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Net Debt: 239000.00
ONMD income_statement (quarterly, 2025-09-30) — Net Income: -741000.00
ONMD income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -741000.00
ONMD income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -741000.00
ONMD income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -741000.00
ONMD income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -741000.00
ONMD cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -741000.00
ONMD income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -741000.00
ONMD income_statement (quarterly, 2025-09-30) — Net Interest Income: -6000.00
ONMD cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 1108000.00
ONMD cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -12000.00
ONMD cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
ONMD income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -6000.00
ONMD cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 500000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Net PPE: 60000.00
ONMD cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
ONMD cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -12000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -3939000.00
ONMD income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2233000.00
ONMD income_statement (quarterly, 2025-09-30) — Normalized Income: -2249000.00
ONMD cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1558000.00
ONMD cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 440000.00
ONMD income_statement (quarterly, 2025-09-30) — Operating Income: -2235000.00
ONMD income_statement (quarterly, 2025-09-30) — Operating Revenue: 177000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 49725274.00
ONMD balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 115000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 388000.00
ONMD income_statement (quarterly, 2025-09-30) — Other Gand A: 1386000.00
ONMD income_statement (quarterly, 2025-09-30) — Other Income Expense: 1500000.00
ONMD cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -1862000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 440000.00
ONMD income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -8000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Other Payable: 727000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 600000.00
ONMD income_statement (quarterly, 2025-09-30) — Other Special Charges: -1821000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Payables: 727000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3847000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
ONMD income_statement (quarterly, 2025-09-30) — Pretax Income: -741000.00
ONMD cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -200000.00
ONMD cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
ONMD balance_sheet (quarterly, 2025-09-30) — Receivables: 582000.00
ONMD income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 399000.00
ONMD income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 10000.00
ONMD cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -12000.00
ONMD income_statement (quarterly, 2025-09-30) — Research And Development: 323000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -101230000.00
ONMD cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 1308000.00
ONMD income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 304000.00
ONMD income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1690000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Share Issued: 49913019.00
ONMD cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 0.00
ONMD cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -12000.00
ONMD income_statement (quarterly, 2025-09-30) — Special Income Charges: 1821000.00
ONMD cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 142000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -3939000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -3939000.00
ONMD income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ONMD income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ONMD balance_sheet (quarterly, 2025-09-30) — Total Assets: 1506000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -3939000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Total Debt: 388000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -3939000.00
ONMD income_statement (quarterly, 2025-09-30) — Total Expenses: 2412000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 5445000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 60000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 440000.00
ONMD income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2235000.00
ONMD income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1508000.00
ONMD income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1508000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 187745.00
ONMD balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 529000.00
ONMD cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -55000.00
ONMD balance_sheet (quarterly, 2025-09-30) — Working Capital: -3559000.00
ONMD income_statement (annual, 2025-12-31) — +Operating Expense: 9164000.00
ONMD income_statement (quarterly, 2025-12-31) — +Operating Expense: 3247000.00
ONMD income_statement (annual, 2025-12-31) — +Total Revenue: 265637.22
ONMD income_statement (quarterly, 2025-12-31) — +Total Revenue: 174159.50
ONMD balance_sheet (annual, 2025-12-31) — Accounts Receivable: 495000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 495000.00
ONMD balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -282000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -282000.00
ONMD balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 101932000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 101932000.00
ONMD balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ONMD balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ONMD income_statement (annual, 2025-12-31) — Basic Average Shares: 44547815.00
ONMD income_statement (annual, 2025-12-31) — Basic EPS: -0.06
ONMD cash_flow (annual, 2025-12-31) — Beginning Cash Position: 172000.00
ONMD cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 149000.00
ONMD cash_flow (annual, 2025-12-31) — Capital Expenditure: -13000.00
ONMD cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5000.00
ONMD balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
ONMD balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 585000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 585000.00
ONMD balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1091000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1091000.00
ONMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5609000.00
ONMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2200000.00
ONMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2307000.00
ONMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -51000.00
ONMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -7503000.00
ONMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1713000.00
ONMD cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -172000.00
ONMD cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -349000.00
ONMD cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 366000.00
ONMD cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 314000.00
ONMD cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 194000.00
ONMD cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -76000.00
ONMD cash_flow (annual, 2025-12-31) — Change In Receivables: -282000.00
ONMD cash_flow (quarterly, 2025-12-31) — Change In Receivables: 87000.00
ONMD cash_flow (annual, 2025-12-31) — Change In Working Capital: 106000.00
ONMD cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -24000.00
ONMD cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -282000.00
ONMD cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 87000.00
ONMD cash_flow (annual, 2025-12-31) — Changes In Cash: 413000.00
ONMD cash_flow (quarterly, 2025-12-31) — Changes In Cash: 436000.00
ONMD balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
ONMD balance_sheet (annual, 2025-12-31) — Common Stock Equity: -2965000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -2965000.00
ONMD cash_flow (annual, 2025-12-31) — Common Stock Issuance: 2497000.00
ONMD cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
ONMD income_statement (annual, 2025-12-31) — Cost Of Revenue: 1862000.00
ONMD income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 726000.00
ONMD balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 3205000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 3205000.00
ONMD balance_sheet (annual, 2025-12-31) — Current Assets: 2095000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Current Assets: 2095000.00
ONMD balance_sheet (annual, 2025-12-31) — Current Debt: 350000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Current Debt: 350000.00
ONMD balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 350000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 350000.00
ONMD balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 389000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 389000.00
ONMD balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 389000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 389000.00
ONMD balance_sheet (annual, 2025-12-31) — Current Liabilities: 4825000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4825000.00
ONMD balance_sheet (annual, 2025-12-31) — Current Notes Payable: 0.00
ONMD balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 0.00
ONMD cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 65000.00
ONMD cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 9000.00
ONMD cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 65000.00
ONMD cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 9000.00
ONMD balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 71000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 71000.00
ONMD income_statement (annual, 2025-12-31) — Diluted Average Shares: 44547815.00
ONMD income_statement (annual, 2025-12-31) — Diluted EPS: -0.06
ONMD income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -2801000.00
ONMD income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3140000.00
ONMD income_statement (annual, 2025-12-31) — EBIT: -2733000.00
ONMD income_statement (quarterly, 2025-12-31) — EBIT: -3131000.00
ONMD income_statement (annual, 2025-12-31) — EBITDA: -2668000.00
ONMD income_statement (quarterly, 2025-12-31) — EBITDA: -3122000.00
ONMD cash_flow (annual, 2025-12-31) — End Cash Position: 585000.00
ONMD cash_flow (quarterly, 2025-12-31) — End Cash Position: 585000.00
ONMD cash_flow (annual, 2025-12-31) — Financing Cash Flow: 5609000.00
ONMD cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2200000.00
ONMD cash_flow (annual, 2025-12-31) — Free Cash Flow: -7516000.00
ONMD cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1718000.00
ONMD cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -1082000.00
ONMD cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -206000.00
ONMD income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 137000.00
ONMD income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 11000.00
ONMD income_statement (annual, 2025-12-31) — General And Administrative Expense: 6377000.00
ONMD income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2378000.00
ONMD balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 495000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 495000.00
ONMD balance_sheet (annual, 2025-12-31) — Gross PPE: 338000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Gross PPE: 338000.00
ONMD income_statement (annual, 2025-12-31) — Gross Profit: -551840.50
ONMD income_statement (quarterly, 2025-12-31) — Gross Profit: -551840.50
ONMD cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1000.00
ONMD cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1000.00
ONMD income_statement (annual, 2025-12-31) — Interest Expense: 67000.00
ONMD income_statement (quarterly, 2025-12-31) — Interest Expense: 8000.00
ONMD income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 67000.00
ONMD income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 8000.00
ONMD cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 23000.00
ONMD cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: -10000.00
ONMD balance_sheet (annual, 2025-12-31) — Invested Capital: -2395000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Invested Capital: -2395000.00
ONMD cash_flow (annual, 2025-12-31) — Investing Cash Flow: 2307000.00
ONMD cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -51000.00
ONMD cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 2497000.00
ONMD cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
ONMD cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2537000.00
ONMD cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2537000.00
ONMD balance_sheet (annual, 2025-12-31) — Long Term Debt: 220000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 220000.00
ONMD balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 220000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 220000.00
ONMD cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -663000.00
ONMD cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -663000.00
ONMD balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 338000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 338000.00
ONMD cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 2497000.00
ONMD cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 11000.00
ONMD income_statement (annual, 2025-12-31) — Net Income: -2801000.00
ONMD income_statement (quarterly, 2025-12-31) — Net Income: -3140000.00
ONMD income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -2801000.00
ONMD income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3140000.00
ONMD income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -2801000.00
ONMD income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3140000.00
ONMD income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2801000.00
ONMD income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3140000.00
ONMD income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2801000.00
ONMD income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3140000.00
ONMD cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -2801000.00
ONMD cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3140000.00
ONMD income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -2801000.00
ONMD income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3140000.00
ONMD income_statement (annual, 2025-12-31) — Net Interest Income: -67000.00
ONMD income_statement (quarterly, 2025-12-31) — Net Interest Income: -8000.00
ONMD cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 2320000.00
ONMD cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -46000.00
ONMD cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 1874000.00
ONMD cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 2148000.00
ONMD cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -663000.00
ONMD cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -663000.00
ONMD income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -67000.00
ONMD income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -8000.00
ONMD cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 1178000.00
ONMD cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -19000.00
ONMD balance_sheet (annual, 2025-12-31) — Net PPE: 56000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Net PPE: 56000.00
ONMD cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -13000.00
ONMD cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -5000.00
ONMD cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 2537000.00
ONMD cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 2811000.00
ONMD balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -2965000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -2965000.00
ONMD income_statement (annual, 2025-12-31) — Normalized EBITDA: -8333000.00
ONMD income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3133000.00
ONMD income_statement (annual, 2025-12-31) — Normalized Income: -8466000.00
ONMD income_statement (quarterly, 2025-12-31) — Normalized Income: -3151000.00
ONMD cash_flow (annual, 2025-12-31) — Operating Cash Flow: -7503000.00
ONMD cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1713000.00
ONMD cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1041000.00
ONMD cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -206000.00
ONMD income_statement (annual, 2025-12-31) — Operating Income: -3798840.50
ONMD income_statement (quarterly, 2025-12-31) — Operating Income: -3798840.50
ONMD income_statement (annual, 2025-12-31) — Operating Revenue: 265637.22
ONMD income_statement (quarterly, 2025-12-31) — Operating Revenue: 174159.50
ONMD balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 51984474.00
ONMD balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 51984474.00
ONMD balance_sheet (annual, 2025-12-31) — Other Current Assets: 509000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 509000.00
ONMD balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 350000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 350000.00
ONMD balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 590000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 590000.00
ONMD income_statement (annual, 2025-12-31) — Other Gand A: 6377000.00
ONMD income_statement (quarterly, 2025-12-31) — Other Gand A: 2378000.00
ONMD income_statement (annual, 2025-12-31) — Other Income Expense: 6934000.00
ONMD income_statement (quarterly, 2025-12-31) — Other Income Expense: -49000.00
ONMD cash_flow (annual, 2025-12-31) — Other Non Cash Items: -6809000.00
ONMD cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 0.00
ONMD income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1269000.00
ONMD income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -60000.00
ONMD balance_sheet (annual, 2025-12-31) — Other Payable: 291000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Other Payable: 291000.00
ONMD balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 506000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 506000.00
ONMD income_statement (annual, 2025-12-31) — Other Special Charges: -5528000.00
ONMD income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
ONMD balance_sheet (annual, 2025-12-31) — Payables: 291000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Payables: 291000.00
ONMD balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3496000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3496000.00
ONMD balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
ONMD balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
ONMD income_statement (annual, 2025-12-31) — Pretax Income: -2800000.00
ONMD income_statement (quarterly, 2025-12-31) — Pretax Income: -3139000.00
ONMD cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 60000.00
ONMD cash_flow (annual, 2025-12-31) — Purchase Of Investment: -2750000.00
ONMD cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -350000.00
ONMD cash_flow (annual, 2025-12-31) — Purchase Of PPE: -13000.00
ONMD cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -5000.00
ONMD balance_sheet (annual, 2025-12-31) — Receivables: 495000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Receivables: 495000.00
ONMD income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1862000.00
ONMD income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 726000.00
ONMD income_statement (annual, 2025-12-31) — Reconciled Depreciation: 65000.00
ONMD income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 9000.00
ONMD cash_flow (annual, 2025-12-31) — Repayment Of Debt: -663000.00
ONMD cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -389000.00
ONMD income_statement (annual, 2025-12-31) — Research And Development: 1515000.00
ONMD income_statement (quarterly, 2025-12-31) — Research And Development: 443000.00
ONMD balance_sheet (annual, 2025-12-31) — Retained Earnings: -104370000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -104370000.00
ONMD cash_flow (annual, 2025-12-31) — Sale Of Investment: 5070000.00
ONMD cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 304000.00
ONMD income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1272000.00
ONMD income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 426000.00
ONMD income_statement (annual, 2025-12-31) — Selling General And Administration: 7649000.00
ONMD income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2804000.00
ONMD balance_sheet (annual, 2025-12-31) — Share Issued: 52172219.00
ONMD balance_sheet (quarterly, 2025-12-31) — Share Issued: 52172219.00
ONMD cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 2537000.00
ONMD cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 2537000.00
ONMD cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
ONMD cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 274000.00
ONMD income_statement (annual, 2025-12-31) — Special Income Charges: 5528000.00
ONMD income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
ONMD cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2032000.00
ONMD cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1485000.00
ONMD balance_sheet (annual, 2025-12-31) — Stockholders Equity: -2965000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -2965000.00
ONMD balance_sheet (annual, 2025-12-31) — Tangible Book Value: -2965000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -2965000.00
ONMD income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ONMD income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ONMD income_statement (annual, 2025-12-31) — Tax Provision: 1000.00
ONMD income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
ONMD income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
ONMD balance_sheet (annual, 2025-12-31) — Total Assets: 2151000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Total Assets: 2151000.00
ONMD balance_sheet (annual, 2025-12-31) — Total Capitalization: -2745000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -2745000.00
ONMD balance_sheet (annual, 2025-12-31) — Total Debt: 570000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Total Debt: 570000.00
ONMD balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -2965000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -2965000.00
ONMD income_statement (annual, 2025-12-31) — Total Expenses: 11026000.00
ONMD income_statement (quarterly, 2025-12-31) — Total Expenses: 3973000.00
ONMD balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 5116000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 5116000.00
ONMD balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 56000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 56000.00
ONMD balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 291000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 291000.00
ONMD income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -9667000.00
ONMD income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -3082000.00
ONMD income_statement (annual, 2025-12-31) — Total Unusual Items: 5665000.00
ONMD income_statement (quarterly, 2025-12-31) — Total Unusual Items: 11000.00
ONMD income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 5665000.00
ONMD income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 11000.00
ONMD balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 187745.00
ONMD balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 187745.00
ONMD balance_sheet (annual, 2025-12-31) — Treasury Stock: 529000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 529000.00
ONMD cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 945000.00
ONMD cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 163000.00
ONMD balance_sheet (annual, 2025-12-31) — Working Capital: -2730000.00
ONMD balance_sheet (quarterly, 2025-12-31) — Working Capital: -2730000.00
ONMD income_statement (quarterly, 2026-03-31) — +Operating Expense: 2172000.00
ONMD income_statement (quarterly, 2026-03-31) — +Total Revenue: 96000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 697000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 103268000.00
ONMD income_statement (quarterly, 2026-03-31) — Basic Average Shares: 55316371.00
ONMD income_statement (quarterly, 2026-03-31) — Basic EPS: -0.04
ONMD cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 585000.00
ONMD cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Capital Stock: 5000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 233000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 299000.00
ONMD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 838000.00
ONMD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 352000.00
ONMD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1542000.00
ONMD cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 290000.00
ONMD cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 445000.00
ONMD cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 45000.00
ONMD cash_flow (quarterly, 2026-03-31) — Change In Receivables: -202000.00
ONMD cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 578000.00
ONMD cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -202000.00
ONMD cash_flow (quarterly, 2026-03-31) — Changes In Cash: -352000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Common Stock: 5000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -4079000.00
ONMD income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 476000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 3630000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Current Assets: 1460000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Current Debt: 661000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 661000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 679000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 679000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5355000.00
ONMD cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 11000.00
ONMD cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 11000.00
ONMD balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 55000.00
ONMD income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 55316371.00
ONMD income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.04
ONMD income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -2453000.00
ONMD income_statement (quarterly, 2026-03-31) — EBIT: -2443000.00
ONMD income_statement (quarterly, 2026-03-31) — EBITDA: -2432000.00
ONMD cash_flow (quarterly, 2026-03-31) — End Cash Position: 233000.00
ONMD cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 838000.00
ONMD cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1544000.00
ONMD cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -7000.00
ONMD income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 109000.00